A new drug for neuroblastoma and three more drugs for rare pediatric diseases approved during Thanksgiving week, earning the vouchers under the Creating Hope Act. more→
CREATING HOPE ACT & PEDIATRIC PRIORITY REVIEW VOUCHERS NEWS
(Washington Post) Reauthorize the Creating Hope Act to help kids with rare diseases
The inspirational story of 10-year-old Autumn Schierling’s fight with neurofibromatosis and the successful development of selumetinib for her condition offer a timely example of how a law can help children with rare diseases. more→
(Congressional testimony by Nancy Goodman) Creating Hope: In Support of the Creating Hope Reauthorization Act, Making the Rare Pediatric Disease Priority Review Voucher Program Permanent
Testimony before the Health Subcommittee of the U.S. House of Representatives Energy and
Commerce Committee, July 29, 2020. Nancy Goodman, Founder of Kids v Cancer more→
(Blog) Creating Hope Act Permanent Reauthorization of 2019
The Creating Hope Act passed in 2012, was reauthorized several times, and sunsets September 30, 2020. The Creating Hope Act pediatric priority more→
(Guidance) FDA Updates Draft Guidance on Pediatric Priority Review Vouchers
FDA expects 51 rare pediatric disease designation requests and 20 priority review voucher requests annually. more→
(video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
Watch our youth advocates and cancer survivors describe their meetings with congressional staffers and advocating for kids with cancer. more→
(Yale Law School – video) Is the Federal government a productive partner in cancer policy?
Watch a 9 min. video: Nancy Goodman speaks about creating incentives for the industry to develop cancer drugs for children at the joint conference of the Yale Law School, Smilow Cancer Hospital and Yale Cancer Center. more→
(RAPS Regulatory Explainer) Everything you need to know about FDA’s Priority Review Vouchers
What are the Priority Review Vouchers and how do they benefit the society? more→
(Morning Consult) Don’t leave them waiting: How to bring new cancer drugs to kids, by Elena Gerasimov)
The RACE Act is needed because most kids with cancer are treated with medicines from the time when my mom was young. more→
(STAT News-audio) The death of a child and a golden ticket for drug makers
How did every parent’s worst nightmare — the death of a child — spur the creation of an incentive system to turn making drugs for childhood cancer from a high-risk, low-reward gamble to a bet a company might make? more→
(Blog) Creating Hope Act reauthorized in 21st Century Cures
On December 13, 2016, President Obama signed into law the 21st Century Cures Act, reauthorizing the Creating Hope Act until 2020. more→
(Blog) Congress passes CURES and reuthorizes the Creating Hope Act, 94-5!
U.S. Senate passed the 21st Century Cures Act and with it, reauthorization of the Creating Hope Act. more→
(Blog) The House reauthorized the Creating Hope Act
In a vote of 392 – 26, the House passed 21st Century Cures, which includes the Creating Hope Act Pediatric Priority Review Voucher Program. more→
(Blog) President Obama signs the Advancing Hope Act to extend the Creating Hope Act to December 31, 2016
The Creating Hope Act pediatric priority review voucher program is extended until December 31, 2016. more→
(PBS News Hour) How one drug company fast-tracked the FDA’s review process
A voucher program shaves months off of the FDA’s review process for drug development that targets rare pediatric diseases. more→